首页> 美国卫生研究院文献>The Journal of Veterinary Medical Science >High antiviral effects of hibiscus tea extract on the H5 subtypes of low andhighly pathogenic avian influenza viruses
【2h】

High antiviral effects of hibiscus tea extract on the H5 subtypes of low andhighly pathogenic avian influenza viruses

机译:芙蓉茶提取物对低和低H5亚型的高抗病毒作用高致病性禽流感病毒

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Viral neuraminidase inhibitors are widely used as synthetic anti-influenza drugs for the prevention and treatment of influenza. However, drug-resistant influenza A virus variants, including H5N1 highly pathogenic avian influenza viruses (HPAIVs), have been reported. Therefore, the discovery of novel and effective antiviral agents is warranted. We screened the antiviral effects of 11 herbal tea extracts (hibiscus, black tea, tencha, rosehip tea, burdock tea, green tea, jasmine tea, ginger tea, lavender tea, rose tea and oak tea) against the H5N1 HPAIV in vitro. Among the tested extracts, only the hibiscus extract and its fractionated extract (frHibis) highly and rapidly reduced the titers of all H5 HPAIVs and low pathogenic AIVs (LPAIVs) used in the pre-treatment tests of Madin–Darby canine kidney (MDCK) cells that were inoculated with a mixture of the virus and the extract. Immunogold electron microscopy showed that anti-H5 monoclonal antibodies could not bind to the deformed H5 virus particles pretreated with frHibis. In post-treatment tests of MDCK cells cultured in the presence of frHibis after infection with H5N1 HPAIV, the frHibis inhibited viral replication and the expression of viral antigens and genes. Among the plants tested, hibiscus showed the most prominent antiviral effects against both H5 HPAIV and LPAIV.
机译:病毒神经氨酸酶抑制剂被广泛用作预防和治疗流感的合成抗流感药物。但是,已经报告了包括H5N1高致病性禽流感病毒(HPAIV)在内的耐药A型流感病毒变异株。因此,有必要发现新颖有效的抗病毒药物。我们筛选了11种凉茶提取物(芙蓉,红茶,天茶,玫瑰果茶,牛bur茶,绿茶,茉莉花茶,姜茶,薰衣草茶,玫瑰茶和橡树茶)对H5N1 HPAIV的抗病毒作用。在测试的提取物中,只有芙蓉提取物及其分馏提取物(frHibis)高度而迅速地降低了Madin-Darby犬肾(MDCK)细胞预处理测试中使用的所有H5 HPAIV和低致病性AIV(LPAIV)的滴度接种了病毒和提取物的混合物。免疫金电子显微镜显示,抗H5单克隆抗体不能结合用frHibis预处理的变形H5病毒颗粒。在H5N1 HPAIV感染后在存在frHibis的条件下培养的MDCK细胞的后处理测试中,frHibis抑制了病毒复制以及病毒抗原和基因的表达。在测试的植物中,木槿对H5 HPAIV和LPAIV表现出最显着的抗病毒作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号